With a guardant P/E of 14.45x and upside imaginable of 59.60%, Boston Scientific Corporation (NYSE:BSX) ranks among the top 10 lowest guardant P/E stocks successful the S&P 500.
A dose vessel of the medicine is successful the aesculapian tech's manus
Boston Scientific Corporation (NYSE:BSX) has seen a crisp de-rating successful 2026, with shares down astir 50% year-to-date arsenic of June 8, 2026, adjacent arsenic the immense bulk of covering analysts support bullish ratings connected the stock.
The unit constituent is Boston Scientific Corporation (NYSE:BSX)'s Watchman near atrial appendage closure franchise, wherever absorption precocious signaled reduced maturation expectations implicit the adjacent mates of quarters.
On June 3, 2026, BTIG expert Marie Thibault chopped the firm's terms people connected Boston Scientific Corporation (NYSE:BSX) to $65 from $80, keeping a "Buy" rating, aft updating the firm's forecast to bespeak those comments, made astatine a sell-side conference. BTIG said visibility is constricted for present and framed its stance arsenic cautious, modeling flattish Watchman income successful the 2nd and 3rd quarters, a flimsy sequential uptick successful the 4th quarter, and a mild, gradual betterment done 2027.
On June 1, 2026, Canaccord besides trimmed its terms target, to $70 from $71, portion keeping a "Buy" rating. The steadfast updated its exemplary to relationship for Watchman slowdowns successful some 2026 and 2027, which it said transportation antagonistic implications for its gross and EPS estimates.
Despite the people cuts, some firms held their bullish ratings, reflecting the broader Wall Street presumption connected Boston Scientific Corporation (NYSE:BSX).
Boston Scientific Corporation (NYSE:BSX) manufactures, develops, and markets aesculapian devices utilized successful interventional aesculapian procedures. Its operations are divided into Cardiovascular and MedSurg segments. The Cardiovascular conception covers Cardiology and Peripheral Interventions, portion the MedSurg conception comprises Urology, Endoscopy, and Neuromodulation.
While we admit the imaginable of BSX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years.
Disclosure: None. Follow Insider Monkey connected Google News.

1 week ago
8




English (CA) ·
English (US) ·
Spanish (MX) ·